Clinical Trials Sponsored by Lilly PharmaceuticalCompany

Total 3503 results

Eli Lilly and Company

Completed

A Study of Duloxetine in Patients With Osteoarthritis Knee Pain

Osteoarthritis Knee Pain

Romania, Spain, United States, Germany, Greece, Puerto Rico, Russian Federation, Sweden
Eli Lilly and Company

Completed

Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma

Colorectal Neoplasms | Metastases, Neoplasm

United States
Eli Lilly and Company

Completed

Long-Term, Open Label Atomoxetine Study

Attention Deficit Hyperactivity Disorder

United States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
Eli Lilly and Company

Completed

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

Diabetes Mellitus, Type 2

United States, Puerto Rico
Eli Lilly and Company

Completed

A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

France
Eli Lilly and Company

Completed

Effect of Tadalafil Once a Day in Men With Erectile Dysfunction

Erectile Dysfunction

Germany, Spain, Italy, Greece, Poland
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Manic or Mixed Episode Associated With Bipolar I Disorder

Japan
Eli Lilly and Company

Completed

Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)

Severe Sepsis

United States, Belgium, Spain, France, Finland, Germany, Canada, United Kingdom, Puerto Rico
Eli Lilly and Company

Completed

Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

Benign Prostatic Hyperplasia

Korea, Republic of
Eli Lilly and Company

Completed

A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.

Erectile Dysfunction

Germany, Spain, United States, Australia, Brazil, Italy, Mexico, Puerto Rico, United Kingdom
Eli Lilly and Company

Completed

Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

China, Taiwan, Korea, Republic of
Eli Lilly and Company

Completed

A Study for Patient With Chronic Low Back Pain

Chronic Low Back Pain

United States, Spain, Brazil, Germany, Netherlands, Poland, Russian Federation
Eli Lilly and Company

Completed

Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
Eli Lilly and Company

Completed

Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Australia, Greece, India, Netherlands, Poland, Puerto Rico
Eli Lilly and Company

Completed

24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine

Type 2 Diabetes

United States
Eli Lilly and Company

Completed

Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy

Solid Tumors

Netherlands
Eli Lilly and Company

Completed

Phase 3 Clinical Trial of Teriparatide in Japan

Osteoporosis

Japan
Eli Lilly and Company

Completed

Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers

Non-small Cell Lung Cancer

China, Korea, Republic of, Taiwan
Eli Lilly and Company

Completed

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Major Depressive Disorder | Idiopathic Parkinson Disease

Italy
Eli Lilly and Company

Completed

A Study in Erectile Dysfunction

Erectile Dysfunction

United States
Eli Lilly and Company

Completed

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

Breast Cancer

India
Eli Lilly and Company

Completed

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) (S019)

Diabetes Mellitus, Type 2

Croatia, Poland, Romania, South Africa, Turkey
Eli Lilly and Company

Completed

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Osteoporosis, Postmenopausal

United States
Eli Lilly and Company

Completed

A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Heart Diseases | Cardiovascular Diseases

United States, Canada
Eli Lilly and Company

Completed

Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen

Metastatic Breast Cancer

Japan
Eli Lilly and Company

Completed

Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line

Breast Cancer

China, India, Turkey, Korea, Republic of, Brazil, Mexico
Eli Lilly and Company

Completed

Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)

Non-Small-Cell Lung Cancer

Germany
Eli Lilly and Company

Completed

Follow-up Data of Patients Treated With XIGRIS® in France

Sepsis

France
Eli Lilly and Company

Completed

Somatropin Treatment to Final Height in Turner Syndrome (GDCT)

Turner Syndrome

Canada
Eli Lilly and Company

Completed

A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

Attention Deficit Hyperactivity Disorder

Korea, Republic of, China, Taiwan
Eli Lilly and Company

Completed

Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

Italy
Eli Lilly and Company

Completed

A Phase III Trial For Patients With Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms | Cancer of the Breast

United States, Argentina, Australia, Brazil, Korea, Republic of, Mexico, Puerto Rico, Taiwan
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in Chronic Low Back Pain

Back Pain Without Radiation

Brazil, France, Germany, Mexico, Netherlands
Eli Lilly and Company

Completed

A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer

Breast Cancer

United States
Eli Lilly and Company

Completed

Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer

Biliary Tract Cancer

Japan
Eli Lilly and Company

Completed

Combination Chemotherapy for Metastatic Breast Cancer

Breast Cancer

Germany, Russian Federation
Eli Lilly and Company

Completed

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) (IOOY)

Diabetes Mellitus Type 2

Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
Eli Lilly and Company

Completed

A Study for Patients With Osteoporosis

Osteoporosis

China
Eli Lilly and Company

Terminated

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Small Cell Lung Cancer | SCLC | Carcinoma, Small Cell

Netherlands, Belgium
Eli Lilly and Company

Completed

Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Italy
Eli Lilly and Company

Completed

A Study for Patients With Schizophrenia

Schizophrenia

Germany, Mexico, Austria, Croatia, Romania, Russian Federation, Argentina, Portugal, South Africa
Eli Lilly and Company

Completed

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

Alzheimer's Disease

United States
Eli Lilly and Company

Completed

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Schizophrenia | Schizoaffective Disorders

United States, Puerto Rico, Mexico, Brazil, Israel, Korea, Republic of, Russian Federation
Eli Lilly and Company

Completed

Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock

Sepsis | Septic Shock

United States
Eli Lilly and Company

Completed

Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

Osteoporosis

United States
Eli Lilly and Company

Completed

A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

Rectal Neoplasms

Sweden
Eli Lilly and Company

Completed

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Bipolar Disorder I or II

France
Eli Lilly and Company

Completed

A Study for Patients With Diabetes Mellitus (IOPA) (IOPA)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Eli Lilly and Company

Completed

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States, Puerto Rico, Netherlands, Canada, Mexico
Eli Lilly and Company

Completed

A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

Bipolar I Disorder

United States

Clinical Trials Sponsored by Lilly PharmaceuticalCompany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations